Quantcast
Last updated on April 21, 2014 at 11:58 EDT

Latest Cat allergy Stories

2010-01-19 05:11:00

OXFORD, England, January 19 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II. Each of these builds on earlier successful phase II results...

2009-12-11 03:00:00

OXFORD, England, December 11 /PRNewswire/ -- - Investment Follows Successful Phase Ii Clinical Results With cat Allergy T-cell Vaccine - Funding to Progress ToleroMune(R) T-cell Allergy Vaccines Into Late-Stage Development Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has completed a GBP15 million ($25 million) fundraising. The investment round, which was led by Imperial Innovations and supported by existing shareholders...

2009-11-20 03:00:00

OXFORD, England, November 20 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therapy, which successfully identified the optimal dosing regimens to progress into late-stage development. The clinical trial, which was the first of its kind in the field of cat allergy immunotherapy, showed that Circassia's ToleroMune treatment was...

2009-06-24 07:40:00

Following a successful pilot, the Pet Buddies program will give company's scientifically proven hypoallergenic cats free of cost to allergic children undergoing treatment for life-threatening diseases LAS VEGAS, June 24 /PRNewswire/ -- Those who have a companion animal understand that the human-animal bond provides important benefits, including the positive effects on those undergoing therapy for life-threatening diseases. Following a successful pilot conducted in 2008, ALLERCA Lifestyle...

2008-12-19 06:00:00

New Hope for Pet Lovers With Allergies IRVINGTON, N.Y., Dec. 19 /PRNewswire/ -- President-elect Obama promised his daughter Malia a puppy during his Election Night address, yet her well-publicized allergies are standing in the way. Fortunately, the recent launch of a breakthrough allergy preventative for children called Little Allergies(TM) Allergen Block may be just what the first family needs to respond, "Yes, we can get a dog!" Little Allergies Allergen Block and new Chloraseptic...

2008-10-03 09:00:38

Circassia, a specialty biopharmaceutical company, has started a further Phase II clinical study of its ToleroMune technology in the field of cat allergy. The trial builds on positive results achieved in an earlier Phase II study, which demonstrated the potential clinical benefits of the ToleroMune approach to allergy desensitization. In the previous Phase II clinical trial, patients experienced substantially reduced reactions to cat allergens after a single administration of ToleroMune...

2008-10-02 06:00:34

OXFORD, England, October 2 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on the fields of allergy and critical care, today announced the start of a further phase II clinical study of its ToleroMune(R) technology in the field of cat allergy. The trial builds on positive results achieved in an earlier phase II study, which demonstrated the potential clinical benefits of the ToleroMune approach to allergy desensitization. In the previous phase II clinical trial,...

2008-09-24 18:00:40

IRVINGTON, N.Y., Sept. 24 /PRNewswire/ -- Prestige Brands Holdings, Inc. announces the launch of Chloraseptic(TM) Allergen Block and Little Allergies(TM) Allergen Block. These over-the-counter products use an innovative scientific-based approach to help prevent nasal allergy symptoms by blocking allergens in the air on contact, before they enter the nasal passages. Allergen Block products, sold under the Chloraseptic(TM) brand for adults and the Little Remedies(TM) brand for children, are...

2008-09-15 09:00:11

By Nicole Warburton Deseret News Stupid allergies. Do you have the symptoms? Runny nose. Coughing. Sneezing. Itchy eyes. The disgusting feeling that your brain may be swimming in a pool of mucus. Just this month, the Asthma and Allergy Foundation of America released its annual fall allergy report, which ranked Salt Lake City as No. 58 on a list of the 100 worst cities for people affected by airborne allergens this season. That's an increase over last year, when the city ranked at 63....

2008-09-11 12:00:43

Circassia, a specialty biopharmaceutical company, has announced positive results from a Phase II clinical study of its anti-allergy technology, ToleroMune, in the field of cat allergy. The trial showed that ToleroMune treatment can substantially reduce allergic reactions to the allergen that causes most cat allergies, and importantly was well tolerated by all patients. Circassia conducted the double-blind study in Germany, where patients with a confirmed history of cat allergies received...